ACR Appropriateness Criteria® Nuchal Translucency Evaluation at 11 to 14 Weeks of Gestation.

AUC Appropriate Use Criteria Appropriateness Criteria Fetal aneuploidy Fetal anomalies Nuchal translucency

Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 26 08 2020
accepted: 01 09 2020
entrez: 6 11 2020
pubmed: 7 11 2020
medline: 22 6 2021
Statut: ppublish

Résumé

A fetus with an increased nuchal translucency at 11 to 14 weeks gestation is at risk for aneuploidy, genetic syndromes, structural anomalies, and intrauterine fetal demise in both single and twin gestations. In addition to referral to genetics for counseling and consideration of diagnostic genetic testing, a detailed anatomic survey and fetal echocardiogram are indicated in the second trimester to screen for congenital malformations and major heart defects. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Identifiants

pubmed: 33153556
pii: S1546-1440(20)30947-9
doi: 10.1016/j.jacr.2020.09.007
pii:
doi:

Types de publication

Practice Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S447-S458

Informations de copyright

Copyright © 2020 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Lynn Simpson (L)

Columbia University, New York, New York; American College of Obstetricians and Gynecologists. Electronic address: ls731@columbia.edu.

Katherine E Maturen (KE)

Panel Chair, University of Michigan, Ann Arbor, Michigan.

Vickie A Feldstein (VA)

University of California San Francisco, San Francisco, California.

Edward R Oliver (ER)

Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Liina Poder (L)

University of California San Francisco, San Francisco, California.

Loretta M Strachowski (LM)

University of California San Francisco, San Francisco, California.

Betsy L Sussman (BL)

The University of Vermont Medical Center, Burlington, Vermont.

Therese M Weber (TM)

University of Alabama at Birmingham, Birmingham, Alabama.

Tom Winter (T)

University of Utah, Salt Lake City, Utah.

Carolyn M Zelop (CM)

Valley Hospital, Ridgewood, New Jersey and NYU School of Medicine, New York, New York; American College of Obstetricians and Gynecologists.

Phyllis Glanc (P)

Specialty Chair, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH